Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where R. Brian Lowry is active.

Publication


Featured researches published by R. Brian Lowry.


Human Mutation | 2009

GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype.

William A. Paznekas; Barbara Karczeski; Sascha Vermeer; R. Brian Lowry; Martin B. Delatycki; Faivre Laurence; Pasi A. Koivisto; Lionel Van Maldergem; Simeon A. Boyadjiev; Joann Bodurtha; Ethylin Wang Jabs

The predominantly autosomal dominant disorder, oculodentodigital dysplasia (ODDD) has high penetrance with intra‐ and interfamilial phenotypic variability. Abnormalities observed in ODDD affect the eye, dentition, and digits of the hands and feet. Patients present with a characteristic facial appearance, narrow nose, and hypoplastic alae nasi. Neurological problems, including dysarthria, neurogenic bladder disturbances, spastic paraparesis, ataxia, anterior tibial muscle weakness, and seizures, are known to occur as well as conductive hearing loss, cardiac defects, and anomalies of the skin, hair, and nails. In 2003, our analysis of 17 ODDD families revealed that each had a different mutation within the human gap junction alpha 1 (GJA1) gene which encodes the protein connexin 43 (Cx43). Since then at least 17 publications have identified an additional 26 GJA1 mutations and in this study, we present 28 new cases with 18 novel GJA1 mutations. We include tables summarizing the 62 known GJA1 nucleotide changes leading to Cx43 protein alterations and the phenotypic information available on 177 affected individuals from 54 genotyped families. Mutations resulting in ODDD occur in each of the nine domains of the Cx43 protein, and we review our functional experiments and those in the literature, examining the effects of 13 different Cx43 mutations upon gap junction activity. Hum Mutat 0, 1–10, 2009.


American Journal of Medical Genetics Part A | 2007

Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients†

Julie C. Sapp; Joyce T. Turner; Jiddeke M. van de Kamp; Fleur S. van Dijk; R. Brian Lowry; Leslie G. Biesecker

We present a series of seven patients who were previously diagnosed with Proteus syndrome, but who do not meet published diagnostic criteria for this disorder and whose natural history is distinct from that of Proteus syndrome. This newly recognized phenotype comprises progressive, complex, and mixed truncal vascular malformations, dysregulated adipose tissue, varying degrees of scoliosis, and enlarged bony structures without progressive bony overgrowth. We have named this condition congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) on a heuristic basis. In contrast to the bony distortion so characteristic of Proteus syndrome, distortion in CLOVE syndrome occurs only following major or radical surgery. Here, we contrast differences and similarities of CLOVE syndrome to Proteus syndrome.


American Journal of Human Genetics | 2013

Mutations in BICD2, which Encodes a Golgin and Important Motor Adaptor, Cause Congenital Autosomal-Dominant Spinal Muscular Atrophy

Kornelia Neveling; Lilian A. Martinez-Carrera; Irmgard Hölker; Angelien Heister; Aad Verrips; Seyyed Mohsen Hosseini-Barkooie; Christian Gilissen; Sascha Vermeer; Maartje Pennings; Rowdy Meijer; Margot te Riele; Catharina J.M. Frijns; Oksana Suchowersky; Linda MacLaren; Sabine Rudnik-Schöneborn; Richard J. Sinke; Klaus Zerres; R. Brian Lowry; Henny H. Lemmink; Lutz Garbes; Joris A. Veltman; Helenius J. Schelhaas; H. Scheffer; Brunhilde Wirth

Spinal muscular atrophy (SMA) is a heterogeneous group of neuromuscular disorders caused by degeneration of lower motor neurons. Although functional loss of SMN1 is associated with autosomal-recessive childhood SMA, the genetic cause for most families affected by dominantly inherited SMA is unknown. Here, we identified pathogenic variants in bicaudal D homolog 2 (Drosophila) (BICD2) in three families afflicted with autosomal-dominant SMA. Affected individuals displayed congenital slowly progressive muscle weakness mainly of the lower limbs and congenital contractures. In a large Dutch family, linkage analysis identified a 9q22.3 locus in which exome sequencing uncovered c.320C>T (p.Ser107Leu) in BICD2. Sequencing of 23 additional families affected by dominant SMA led to the identification of pathogenic variants in one family from Canada (c.2108C>T [p.Thr703Met]) and one from the Netherlands (c.563A>C [p.Asn188Thr]). BICD2 is a golgin and motor-adaptor protein involved in Golgi dynamics and vesicular and mRNA transport. Transient transfection of HeLa cells with all three mutant BICD2 cDNAs caused massive Golgi fragmentation. This observation was even more prominent in primary fibroblasts from an individual harboring c.2108C>T (p.Thr703Met) (affecting the C-terminal coiled-coil domain) and slightly less evident in individuals with c.563A>C (p.Asn188Thr) (affecting the N-terminal coiled-coil domain). Furthermore, BICD2 levels were reduced in affected individuals and trapped within the fragmented Golgi. Previous studies have shown that Drosophila mutant BicD causes reduced larvae locomotion by impaired clathrin-mediated synaptic endocytosis in neuromuscular junctions. These data emphasize the relevance of BICD2 in synaptic-vesicle recycling and support the conclusion that BICD2 mutations cause congenital slowly progressive dominant SMA.


Human Molecular Genetics | 2014

Disruption of the ASTN2 / TRIM32 locus at 9q33.1 is a risk factor in males for Autism Spectrum Disorders, ADHD and other neurodevelopmental phenotypes

Anath C. Lionel; Kristiina Tammimies; Andrea K. Vaags; Jill A. Rosenfeld; Joo Wook Ahn; Daniele Merico; Abdul Noor; Cassandra K. Runke; Vamsee Pillalamarri; Melissa T. Carter; Matthew J. Gazzellone; Bhooma Thiruvahindrapuram; Christina Fagerberg; Lone W. Laulund; Giovanna Pellecchia; Sylvia Lamoureux; Charu Deshpande; Jill Clayton-Smith; Ann C White; Susan Leather; John Trounce; H. Melanie Bedford; Eli Hatchwell; Peggy S. Eis; Ryan K. C. Yuen; Susan Walker; Mohammed Uddin; Michael T. Geraghty; Sarah Nikkel; Eva M Tomiak

Rare copy number variants (CNVs) disrupting ASTN2 or both ASTN2 and TRIM32 have been reported at 9q33.1 by genome-wide studies in a few individuals with neurodevelopmental disorders (NDDs). The vertebrate-specific astrotactins, ASTN2 and its paralog ASTN1, have key roles in glial-guided neuronal migration during brain development. To determine the prevalence of astrotactin mutations and delineate their associated phenotypic spectrum, we screened ASTN2/TRIM32 and ASTN1 (1q25.2) for exonic CNVs in clinical microarray data from 89 985 individuals across 10 sites, including 64 114 NDD subjects. In this clinical dataset, we identified 46 deletions and 12 duplications affecting ASTN2. Deletions of ASTN1 were much rarer. Deletions near the 3 terminus of ASTN2, which would disrupt all transcript isoforms (a subset of these deletions also included TRIM32), were significantly enriched in the NDD subjects (P = 0.002) compared with 44 085 population-based controls. Frequent phenotypes observed in individuals with such deletions include autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), speech delay, anxiety and obsessive compulsive disorder (OCD). The 3-terminal ASTN2 deletions were significantly enriched compared with controls in males with NDDs, but not in females. Upon quantifying ASTN2 human brain RNA, we observed shorter isoforms expressed from an alternative transcription start site of recent evolutionary origin near the 3 end. Spatiotemporal expression profiling in the human brain revealed consistently high ASTN1 expression while ASTN2 expression peaked in the early embryonic neocortex and postnatal cerebellar cortex. Our findings shed new light on the role of the astrotactins in psychopathology and their interplay in human neurodevelopment.


American Journal of Medical Genetics Part A | 2010

How Valid Are the Rates of Down Syndrome Internationally? Findings from the International Clearinghouse for Birth Defects Surveillance and Research

Emanuele Leoncini; Lorenzo D. Botto; Guido Cocchi; Göran Annerén; Carol Bower; Jane Halliday; Emmanuelle Amar; Marian K. Bakker; Sebastiano Bianca; Maria Aurora Canessa Tapia; Eduardo E. Castilla; Melinda Csáky-Szunyogh; Saeed Dastgiri; Marcia L. Feldkamp; Miriam Gatt; Fumiki Hirahara; Danielle Landau; R. Brian Lowry; Lisa Marengo; Robert McDonnell; Triphti M. Mathew; Margery Morgan; Osvaldo Mutchinick; Anna Pierini; Simone Poetzsch; Annukka Ritvanen; Gioacchino Scarano; Csaba Siffel; Antonín Šípek; Elena Szabova

Rates of Down syndrome (DS) show considerable international variation, but a systematic assessment of this variation is lacking. The goal of this study was to develop and test a method to assess the validity of DS rates in surveillance programs, as an indicator of quality of ascertainment. The proposed method compares the observed number of cases with DS (livebirths plus elective pregnancy terminations, adjusted for spontaneous fetal losses that would have occurred if the pregnancy had been allowed to continue) in each single year of maternal age, with the expected number of cases based on the best‐published data on rates by year of maternal age. To test this method we used data from birth years 2000 to 2005 from 32 surveillance programs of the International Clearinghouse for Birth Defects Surveillance and Research. We computed the adjusted observed versus expected ratio (aOE) of DS birth prevalence among women 25–44 years old. The aOE ratio was close to unity in 13 programs (the 95% confidence interval included 1), above 1 in 2 programs and below 1 in 18 programs (Pu2009<u20090.05). These findings suggest that DS rates internationally can be evaluated simply and systematically, and underscores how adjusting for spontaneous fetal loss is crucial and feasible. The aOE ratio can help better interpret and compare the reported rates, measure the degree of under‐ or over‐registration, and promote quality improvement in surveillance programs that will ultimately provide better data for research, service planning, and public health programs.


Clinical Genetics | 2008

X-linked recessive nephritis with mental retardation, sensorineural hearing loss, and macrocephaly

W. Lane M. Robson; R. Brian Lowry; Alexander K. C. Leung

A family with hereditary nephritis, sensorineural hearing loss, macrocephaly, and mental retardation is reported. X‐linked recessive inheritance was suggested by the presence of two affected brothers and a maternal uncle. This association may be a previously unreported variant of Alports syndrome.


American Journal of Medical Genetics Part A | 2005

A locus for Bowen–Conradi syndrome maps to chromosome region 12p13.3†‡

Ryan E. Lamont; J C Loredo-Osti; Nicole M. Roslin; Jill Mauthe; Gail Coghlan; Edward Nylen; Danielle Frappier; A. Micheil Innes; Edward G. Lemire; R. Brian Lowry; Cheryl R. Greenberg; Barbara Triggs-Raine; Kenneth Morgan; Klaus Wrogemann; T. Mary Fujiwara; Teresa Zelinski

Bowen–Conradi syndrome (BCS) is a lethal autosomal recessive disorder with an estimated incidence of 1 in 355 live births in the Hutterite population. A few cases have been reported in other populations. Here, we report the results of a genome‐wide scan and fine mapping of the BCS locus in Hutterite families. By linkage and haplotype analysis the BCS locus was mapped to a 3.5 cM segment (1.9 Mbp) in chromosome region 12p13.3 bounded by F8VWF and D12S397. When genealogical relationships among the families were taken into account in the linkage analysis, the evidence for linkage was stronger and the number of potentially linked regions was reduced to one. Under the assumption that all the Hutterite patients were identical by descent for a disease‐causing mutation, haplotype analysis was used to infer likely historical recombinants and thereby narrow the candidate region to a chromosomal segment shared in common by all the affected children. This study also demonstrates that BCS and cerebro‐oculo‐facial‐skeletal syndrome (COFS) are genetically distinct.


American Journal of Medical Genetics Part A | 2014

De novo exon 1 missense mutations of SKI and Shprintzen-Goldberg syndrome: Two new cases and a clinical review

P.Y. Billie Au; Hilary Racher; John M. Graham; Nancy Kramer; R. Brian Lowry; Jillian S. Parboosingh; A. Micheil Innes

Shprintzen‐Goldberg syndrome (OMIM #182212) is a connective tissue disorder characterized by craniosynostosis, distinctive craniofacial features, skeletal abnormalities, marfanoid body habitus, aortic dilatation, and intellectual disability. Mutations in exon 1 of SKI have recently been identified as being responsible for approximately 90% of reported individuals diagnosed clinically with Shprintzen‐Goldberg syndrome. SKI is a known regulator of TGFβ signaling. Therefore, like Marfan syndrome and Loeys‐Dietz syndrome, Shprintzen‐Goldberg syndrome is likely caused by deregulated TGFβ signals, explaining the considerable phenotypic overlap between these three disorders. We describe two additional patients with exon 1 SKI mutations and review the clinical features and literature of Shprintzen‐Goldberg syndrome.


Birth Defects Research Part A-clinical and Molecular Teratology | 2009

Segregation analysis of cleft lip with or without cleft palate in the First Nations (Amerindian) people of British Columbia and review of isolated cleft palate etiologies

R. Brian Lowry; Candice Y. Johnson; Julian Little

BACKGROUNDnThe First Nations (Amerindian) population of British Columbia, Canada, has the highest reported birth prevalence in the world of cleft lip with or without cleft palate (CL/P) at nearly 3 per 1000 births. In addition, a substantial proportion of cleft palate only (CPO) cases in this population has been reported to be X-linked. The aims of this study were to perform complex segregation analysis to investigate the mode of inheritance of CL/P in the First Nations people of British Columbia and to review the etiology of the CPO cases.nnnMETHODSnAll First Nations children born in British Columbia between 1952 and 1971 with an orofacial cleft were included in the study. Multiple sources of ascertainment were used, so that nearly 100% of live births were identified and included during this time. No stillbirths were found but would likely have been ascertained. Extended pedigrees were constructed from these probands and examination of immediate family members, e.g., parents and siblings, was done wherever possible. Complex segregation analysis included all family members. In addition, a CPO case review was conducted.nnnRESULTSnComplex segregation analysis supports the hypothesis that the most likely mode of inheritance of CL/P in this population is a mixed model; that is, an autosomal major gene with polygenic component. The review of 26 CPO cases showed that a substantial proportion are syndromic.


American Journal of Medical Genetics Part A | 2007

Absence of PITX2, BARX1, and FOXC1 mutations in De Hauwere syndrome (Axenfeld–Rieger anomaly, hydrocephaly, hearing loss): A 25‐year follow up

R. Brian Lowry; Douglas B. Gould; Michael A. Walter; Paul R. Savage

This study reports a 25‐year follow‐up of a patient with De Hauwere syndrome (Axenfeld–Rieger anomaly, hydrocephalus, and hearing loss) whose intelligence is normal. Short stature and hyperlaxity of joints later leading to severe joint pain were noted. Mutation analysis of candidate genes known or suspected to be associated with Axenfeld–Rieger eye malformations was performed. This included complete sequencing for PITX2, BARX1 and the forkhead domain of FOXC1. The results of these analyses were negative and suggest that De Hauwere syndrome is caused by a different gene.

Collaboration


Dive into the R. Brian Lowry's collaboration.

Top Co-Authors

Avatar

John M. Opitz

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Barbara Sibbald

Alberta Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Judy Chernos

Alberta Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tanya Bedard

Alberta Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

A. Micheil Innes

Alberta Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Gerhard Kiefer

Alberta Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ethylin Wang Jabs

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge